Altria posts better-than-expected Q3 results on robust demand for vapes, nicotine pouches

(Reuters) – Altria Group beat market expectations for third-quarter revenue and profit on Thursday, as robust demand for its nicotine pouches and e-cigarettes helped soften the hit to its cigarettes category.

Altria’s NJOY vapes and on! nicotine pouches have seen steady demand in the United States, with its menthol flavored NJOY vape products receiving authorization from the U.S. Food and Drug Administration for sale.

Big tobacco’s bet on alternatives to traditional cigarettes is being watched closely by investors as companies such as Altria and its peers deal with weak demand for cigarettes and face stiff competition from local brands for vapes.

The company said in July it had sent data to the FDA on growth in illegal nicotine pouches, which it said depicted early stages of a massive black market for vapes.

Domestic cigarette shipment volume in the smokeable products segment fell 8.6% in the third quarter, while NJOY devices reported shipment volume increased over 100% year-over-year to 1.1 million units.

Shipment volume for on! nicotine pouches rose 46% in the quarter, while demand continued to weaken for the company’s chewing tobacco products such as Copenhagen.

Shares of the Marlboro maker were up about 1% in premarket trade. They have risen about 25% so far this year.

Altria also unveiled a long-term plan to increase operational efficiency through generative artificial intelligence and automation.

The company added that initial phases of the plan were expected to deliver at least $600 million in cost savings over the next five years.

Quarterly revenue net of excise taxes rose 1.3% to $5.34 billion. Analysts had expected $5.33 billion, according to data compiled by LSEG.

Altria’s third-quarter adjusted earnings per share of $1.38 topped market expectations of $1.35.

The company maintained its annual profit forecast of between $5.07 and $5.15 per share.

Last week, peer Philip Morris lifted its annual profit target betting on strength in demand for its flagship IQOS heated tobacco device as well as ZYN nicotine pouches.

(Reporting by Juveria Tabassum; Editing by Krishna Chandra Eluri)